[1] |
陈伟伟,高润霖,刘力生,等.《中国心血管病报告2014》概要[J].中国循环杂志,2015,30(7):617-622.
|
[2] |
Huffman MD, Bhatnagar D.Novel treatments for cardiovascular disease prevention[J].Cardiovasc Ther,2012,30(5):257-263.
|
[3] |
杨新宏,杨晓峰,闫妹姝,等.冠心病患者血清N端前体脑钠肽测定的临床意义[J].临床检验杂志(电子版),2015,4(3):913-915.
|
[4] |
汪佑诚,王丽.NT-proBNP水平对糖尿病合并冠心病患者心血管事件和预后的影响[J].中国当代医药,2015,7(19):44-46.
|
[5] |
Niki Katsiki, Nikolaos Papanas, Dimitri P Mikhailidis,etal.Glycated hemoglobin A 1c(HbA1c) and diabetes:A new era?[J].Current Medical Research and Opinion,2011,27(S3):7-11.
|
[6] |
Cleland SJ.Cardiovascular risk in double diabetes mellitus--when two worlds collide[J].Nat Rev Endocrinol,2012,8(8):476-485.
|
[7] |
Di LG, Fisci E, Secchi F,et al.Diagnostic accuracy of magnetic resonance angiography for detection of coronary artery disease:a systematic review and meta-analysis[J].Eur Radiol,2016,26(10):3706-3718.
|
[8] |
Stancheva N, Tisheva S, Jordanova V, etal.NTProBNP AND HRV AND OUTCOME IN PATIENTS WITH HEART FAILURE WITH REDUCED VS PRESERVED SYSTOLIC FUNCTION[J].Journal of IMAB-Annual Proceeding (Scientific Papers),2008,14(1):89-94.
|
[9] |
Bayes-Genis A, de Antonio M, Galán A,et al.Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure[J].Eur J Heart Fail,2012,14(1):32-38.
|
[10] |
DU Tong-Xin, Z Z Wang, Cai J, etal.Changes of CGA,NT-proBNP and Hs-CRP Levels in Patients with Coronary Heart Disease and Their Clinical Significance[J].Labeled Immunoassays & Clinical Medicine,2011,18(4):227-229.
|
[11] |
Massimiliano C, Simona S, Bruno M,et al.Clinical Relevance of Different B-Type Natriuretic Peptide Decisional Cutoff Values for the Diagnosis of Congenital Heart Disease in the First Weeks of Life[J]. Pediatric Cardiology,2011,32(4):537-538.
|
[12] |
Suzuki T, Yamazaki T, Yazaki Y.The role of the natriuretic peptides in the cardiovascular system[J].Cardiovascular Research,2001,51(3):489-494.
|
[13] |
Mishra RK, Judson G, Christenson RH,et al.The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent Heart Failure and Death in Patients with Stable Coronary Artery Disease:The Heart and Soul Study[J].Cardiology,2017,137(4):201-206.
|
[14] |
Kuusisto J, Mykkänen L, Pyörälä K,et al.NIDDM and its metabolic control predict coronary heart disease in elderly subjects[J].Diabetes,1994,43(8):960-967.
|
[15] |
Eeg-Olofsson K, Cederholm J, Nilsson PM,et al.New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes:an observational study from the Swedish National Diabetes Register (NDR)[J].J Intern Med,2010,268(5):471-482.
|
[16] |
Silbernagel G, Grammer TB, Winkelmann BR,et al.Glycated hemoglobin predicts all-cause,cardiovascular,and cancer mortality in people without a history of diabetes undergoing coronary angiography[J].Diabetes Care,2011,34(6):1355-1361.
|
[17] |
Korkmaz S, Zitron E, Bangert A,et al.Provocation of an autoimmune response to cardiac voltage-gated sodium channel NaV1.5 induces cardiac conduction defects in rats[J].J Am Coll Cardiol,2013,62(4):340-349.
|
[18] |
Nenna A, Spadaccio C, Lusini M,et al.Basic and Clinical Research Against Advanced Glycation End Products (AGEs):New Compounds to Tackle Cardiovascular Disease and Diabetic Complications[J].Recent Adv Cardiovasc Drug Discov,2015,10(1):10-33.
|
[19] |
Hong LF, Li XL, Guo YL,et al.Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina[J].Lipids Health Dis,2014,13:89.
|
[20] |
Thambiah SC, Samsudin IN, George E,et al.Relationship between dyslipidaemia and glycaemic status in patients with Type 2 diabetes mellitus[J].Malays J Pathol,2016,38(2):123-130.
|